Accuri Cytometers (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Accuri Cytometers

Founded 2004

Ann Arbor, United States 9 employees Series E Total: $32.66M Biotechnology, Health Care +2

Accuri Cytometers is a biotechnology startup founded in 2004 and headquartered in the United States. The company was acquired by BD and is now a wholly owned subsidiary. Accuri Cytometers addresses a critical need in the life sciences field, aiming to make flow cytometry more accessible to researchers. The startup recognizes the challenges researchers face, such as the high cost of instruments, software complexity, maintenance efforts, and space requirements. To tackle these issues, Accuri Cytometers has focused on creating an affordable, robust, and easy-to-use flow cytometer. The company's innovative approach is reflected in its engineering team, which has executed a ground-up design of a new instrument tailored to meet customer-driven specifications. Accuri Cytometers received a significant $6.00M Series E investment on 19 October 2010, with participation from notable investors including Arboretum Ventures, Baird Capital, F-Prime Capital, Flagship Pioneering, and InvestMichigan. This investment is a testament to the confidence these prominent investors have in the potential of Accuri Cytometers' innovative solution in the biotechnology, healthcare, and manufacturing industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Series E	••••••	5		19 Oct 2010
Series D	••••••	6	•••• ••••	10 Aug 2009
Series C	••••••	3		08 Jul 2008
Venture Round	••••••	1		29 Apr 2008
Series B	••••••	-		01 Sep 2007

Funding Stage

Amount

Investors

Lead Investors

Date

Series E

••••••

19 Oct 2010

Series D

••••••

•••• ••••

10 Aug 2009

Series C

••••••

08 Jul 2008

Venture Round

••••••

29 Apr 2008

Series B

••••••

01 Sep 2007

FAQ About Accuri Cytometers

Now a wholly owned subsidiary of BD, Accuri Cytometers, Inc. was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument,...

Accuri Cytometers was founded in 2004.

Accuri Cytometers is headquartered in Ann Arbor, United States.

Accuri Cytometers operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices.

Accuri Cytometers has approximately 9 employees.

Accuri Cytometers has completed 8 funding rounds, raising a total of $32.66M. The latest funding stage is Series E.

Top alternatives and competitors to Accuri Cytometers include Samplix, MicroX Labs Inc, ACEA Biosciences, Kinetic River Corp., Stratedigm, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Accuri Cytometers and Samplix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Accuri Cytometers

General Information

Track Accuri Cytometers

Discover More

About Accuri Cytometers

Funding Rounds & Investors (8)

Accuri Cytometers Alternatives & Competitors

FAQ About Accuri Cytometers

Don't just browse. Track.